ArticleGenetic epidemiology2017
Low-, high-coverage, and two-stage DNA sequencing in the design of the genetic association study.
Article in Genetic epidemiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed.
- The ideal reporting ofPathologica · 2023Review
- Medium-coverage DNA sequencing in the design of the genetic association study.European journal of human genetics : EJHG · 2020Article
- Combining sequence data from multiple studies: Impact of analysis strategies on rare variant calling and association results.Genetic epidemiology · 2020Article
- Genomics and Transcriptomics: The Powerful Technologies in Precision Medicine.International journal of general medicine · 2020Review
- Optimal sequencing depth design for whole genome re-sequencing in pigs.BMC bioinformatics · 2019Article
- Assessment of low-coverage nanopore long read sequencing for SNP genotyping in doubled haploid canola (Brassica napus L.).Scientific reports · 2019Article
- Impact of index hopping and bias towards the reference allele on accuracy of genotype calls from low-coverage sequencing.Genetics, selection, evolution : GSE · 2018Article
- Evaluation and Recommendations for Routine Genotyping Using Skim Whole Genome Re-sequencing in Canola.Frontiers in plant science · 2018Article
- A method for allocating low-coverage sequencing resources by targeting haplotypes rather than individuals.Genetics, selection, evolution : GSE · 2017Article
- Personalized or Precision Medicine? The Example of Cystic Fibrosis.Frontiers in pharmacology · 2017Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Next-generation sequencing-based genetic association study (GAS) is a powerful tool to identify candidate disease variants and genomic regions. Although low-coverage sequencing offers low cost but inadequacy in calling rare variants, high coverage is able to detect essentially every variant but at a high cost. Two-stage sequencing may be an economical way to conduct GAS without losing power. In two-stage sequencing, an affordable number of samples are sequenced at high coverage as the reference panel, then to impute in a larger sample is sequenced at low coverage. As unit sequencing costs continue to decrease, investigators can now conduct GAS with more flexible sequencing depths. Here, we systematically evaluate the effect of the read depth and sample size on the variant discovery power and association power for study designs using low-coverage, high-coverage, and two-stage sequencing. We consider 12 low-coverage, 12 high-coverage, and 51 two-stage design scenarios with the read depth varying from 0.5× to 80×. With state-of-the-art simulation and analysis packages and in-house scripts, we simulate the complete study process from DNA sequencing to SNP (single nucleotide polymorphism) calling and association testing. Our results show that with appropriate allocation of sequencing effort, two-stage sequencing is an effective approach for conducting GAS. We provide practical guidelines for investigators to plan the optimum sequencing-based GAS including two-stage sequencing design given their specific constraints of sequencing investment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.